|
Preclinical analyses of advanced prostate cancer in genetically-engineered mice
|
2R01CA173481-06
|
$385,883
|
|
ABATE-SHEN, CORY
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Master Regulatory MicroRNAs in Glioblastoma
|
5U01CA220841-02
|
$452,813
|
|
ABOUNADER, ROGER
|
UNIVERSITY OF VIRGINIA
|
|
Quantitative MRI for Predicting Response of Breast Cancer to Neoadjuvant Therapy
|
5U01CA142565-10
|
$461,172
|
|
ABRAMSON, RICHARD
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
tDCS for Increasing Exercise Adherence in Individuals with Elevated Depressive Symptoms
|
1R21CA214102-01A1
|
$185,963
|
$185,963
|
ABRANTES, ANA
|
BUTLER HOSPITAL (PROVIDENCE, RI)
|
|
Aerobic Exercise for Smokers with Depressive Symptomatology
|
5R01CA173551-05
|
$509,755
|
$509,755
|
ABRANTES, ANA
|
BUTLER HOSPITAL (PROVIDENCE, RI)
|
|
Center for Multiple Myeloma Nanotherapy
|
5U54CA199092-04
|
$2,184,301
|
|
ACHILEFU, SAMUEL
|
WASHINGTON UNIVERSITY
|
|
Nanoparticle mediated microenvironmental targeting of CCL3 signaling for the treatment of acute myelogenous leukemia
|
1F31CA228391-01
|
$42,418
|
|
ACKUN-FARMMER, MARIAN
|
UNIVERSITY OF ROCHESTER
|
|
WalkIT: Neighborhood walkability and moderation of adaptive walking interventions
|
5R01CA198915-03
|
$514,474
|
$128,619
|
ADAMS, MARC
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Genetic identification of novel mTORC1 regulators and homeostatic signaling mechanisms
|
1F31CA228241-01
|
$44,524
|
|
ADELMANN, CHARLES
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Probing the role of the IRE1alpha-XBP1 pathway in normal and malignant hematopoiesis
|
5K22CA218467-02
|
$192,575
|
|
ADORO, STANLEY
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Developing targeted activatable peptides to amplify radiosensitizer delivery
|
5R03CA219744-02
|
$77,500
|
|
ADVANI, SUNIL
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
New Roles for the WTX Tumor Suppressor and Endocytosis in WNT signaling
|
1F31CA228289-01
|
$34,190
|
|
AGAJANIAN, MEGAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Functional interrogation of epigenetic vulnerabilities in KRAS-mutant pancreatic cancer
|
5K08CA218420-02
|
$177,120
|
|
AGUIRRE, ANDREW
|
DANA-FARBER CANCER INST
|
|
Modulating systemic pro-oncogenic effects of focal image-guided tumor ablation
|
5R01CA197081-03
|
$470,573
|
|
AHMED, MUNEEB
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
MULTIMODAL PRECLINICAL CANCER IMAGING AND THERAPY RESEARCH SPECIALIST
|
5R50CA211481-04
|
$170,003
|
|
AKERS, WALTER
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
Cancer Prevention and Control Health Disparities Training Program
|
5T32CA078447-18
|
$161,530
|
|
ALBERTS, DAVID
|
UNIVERSITY OF ARIZONA
|
|
A collaborative structural hub to promote Cancer Center science and drug design
|
5R50CA211440-03
|
$145,562
|
|
ALESHIN, ALEXANDER
|
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST
|
|
Modulation of wild type and mutant p53 by HMGA1
|
1F32CA221010-01A1
|
$58,654
|
|
ALEXANDER, KATHERINE
|
UNIVERSITY OF PENNSYLVANIA
|
|
Dosage-Dependent Hedgehog Signaling in Pancreatic Cancer
|
5R01CA198074-04
|
$378,171
|
|
ALLEN, BENJAMIN
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Targeting Tumor Initiating Cell in Undifferentiated Pleomorphic Sarcoma
|
5R01CA183811-05
|
$435,560
|
|
ALMAN, BENJAMIN
|
DUKE UNIVERSITY
|
|
Therapeutic resistance in leukemic cells: targeting BCL-2 family and autophagy
|
5R01CA184137-04
|
$362,569
|
|
ALMASAN, ALEXANDRU
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Multi-Tensor Decompositions for Personalized Cancer Diagnostics and Prognostics
|
5U01CA202144-04
|
$741,952
|
|
ALTER, ORLY
|
UNIVERSITY OF UTAH
|
|
Tumor Plasticity
|
5R35CA220446-02
|
$1,140,000
|
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
Molecular mechanisms of BRAF inhibitor induced UPR and autophagy
|
5R01CA198015-04
|
$366,000
|
|
AMARAVADI, RAVI
|
UNIVERSITY OF PENNSYLVANIA
|
|
In vivo regulators of TERT promoter mutant glioblastoma
|
1F32CA228365-01
|
$58,654
|
|
AMEN, ALEXANDRA
|
UNIVERSITY OF CALIFORNIA BERKELEY
|
|
Bitter Melon Component and Colon Cancer Prevention
|
5R01CA190291-05
|
$544,710
|
|
ANANT, SHRIKANT
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
The regulation of dendritic cell function by LMYC at steady state and during immune responses to cancer
|
1F31CA228240-01
|
$30,442
|
|
ANDERSON, DAVID
|
WASHINGTON UNIVERSITY
|
|
Metro-Minnesota Community Clinical Oncology Program (MM-CCOP)
|
5UG1CA189863-06
|
$2,840,966
|
|
ANDERSON, DANIEL
|
HEALTHPARTNERS INSTITUTE
|
|
Evaluation of centrosome amplification as a risk-predictor for breast cancer aggr
|
5U01CA179671-05
|
$303,118
|
|
ANEJA, RITU
|
GEORGIA STATE UNIVERSITY
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
3P30CA142543-08S1
|
$175,000
|
$1,750
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
5P30CA142543-08
|
$2,480,000
|
$24,800
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Cancer Center Support Grant - UT Southwestern Medical Center
|
5P30CA142543-09
|
$2,480,000
|
$24,800
|
ARTEAGA, CARLOS
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Stopping Tyrosine Kinase Inhibitors in CML Patients (Stop-TKIs)
|
5R01CA184798-04
|
$257,562
|
$64,391
|
ATALLAH, EHAB
|
MEDICAL COLLEGE OF WISCONSIN
|
|
A Prospective Study of the Impact of Breast Cancer on Symptoms and Functioning
|
5R01CA199137-03
|
$392,439
|
$98,110
|
AVIS, NANCY
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Understanding the role of persistent telomere cohesion in ALT cancer cells
|
1F31CA221162-01A1
|
$32,041
|
|
AZARM, KAMERON
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Translating buccal nanocytology for lung cancer screening into clinical practice
|
1R01CA225002-01A1
|
$638,469
|
|
BACKMAN, VADIM
|
NORTHWESTERN UNIVERSITY
|
|
Reducing Cancer Transcriptional Heterogeneity through Regulation of Chromatin Structure
|
1R01CA228272-01
|
$659,504
|
|
BACKMAN, VADIM
|
NORTHWESTERN UNIVERSITY
|
|
Macrophage-Microbiota Interactions in Colon Cancer
|
1F31CA225044-01A1
|
$35,917
|
|
BADER, JACKIE
|
UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA
|
|
University of Washington/Fred Hutch Center for AIDS Research
|
2P30AI027757-31
|
$508,801
|
|
BAETEN, JARED
|
UNIVERSITY OF WASHINGTON
|
|
Puerto Rico NCI Community Oncology Research Program Minority/Underserved
|
5UG1CA189862-05
|
$717,072
|
|
BAEZ- DIAZ, LUIS
|
COMPREHENSIVE CANCER CENTER/ UNIV/PR
|
|
Bay Area Tumor Institute NCORP
|
5UG1CA189817-05
|
$826,500
|
|
BAILEY, LISA
|
BAY AREA TUMOR INSTITUTE
|
|
Tyrosine kinase inhibitors for the treatment of childhood AML
|
5R01CA138744-09
|
$343,388
|
|
BAKER, SHARYN
|
OHIO STATE UNIVERSITY
|
|
Vesicular Stomatitis Virus (VSV) Replication in Malignant Cells
|
5R01CA194404-04
|
$334,911
|
|
BARBER, GLEN
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Tumor Suppression by an African Specific Variant of p53
|
1F32CA220972-01A1
|
$59,038
|
|
BARNOUD, THIBAUT
|
WISTAR INSTITUTE
|
|
Regulation of Ceramide-Based Therapeutics in Acute Myeloid Leukemia
|
5K22CA190674-04
|
$161,692
|
|
BARTH, BRIAN
|
UNIVERSITY OF NEW HAMPSHIRE
|
|
Early detection of ovarian cancer by serum marker and targeted ultrasound imaging
|
5R01CA210370-03
|
$356,233
|
|
BARUA, ANIMESH
|
RUSH UNIVERSITY MEDICAL CENTER
|
|
Using hunger training to enhance weight loss and modulate cancer-related biomarkers in women at high risk for breast cancer: a pilot study
|
5R21CA215415-02
|
$174,000
|
|
BASEN-ENGQUIST, KAREN
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Therapeutic targeting of Fibroblast Growth Factor Receptors in Squamous Cancers
|
5R01CA196932-04
|
$387,027
|
|
BASS, ADAM
|
DANA-FARBER CANCER INST
|
|
Targeting Mucin and EGFR Axis in Pancreatic Cancer
|
5R01CA183459-05
|
$311,659
|
|
BATRA, SURINDER
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
FrostBite - A Unique Catheter for Endoscopic Cryoablation
|
5R44CA183265-03
|
$737,450
|
|
BAUST, J
|
CELL PRESERVATION SERVICES, INC.
|
Total relevant funding to Depression Research for this search: $15,371,683
|